Outlook Therapeutics (OTLK) EBIT Growth (3y) (2018 - 2026)
Outlook Therapeutics (OTLK) EBIT Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
-27.06% |
| Date | Value |
|---|
| Mar 31, 2026 |
-27.06% |
| Dec 31, 2025 |
4.92% |
| Sep 30, 2025 |
-7.37% |
| Jun 30, 2025 |
2.56% |
| Mar 31, 2025 |
13.14% |
| Dec 31, 2024 |
-18.00% |
| Sep 30, 2024 |
-19.41% |
| Jun 30, 2024 |
-19.46% |
| Mar 31, 2024 |
-14.48% |
| Dec 31, 2023 |
10.06% |
| Sep 30, 2023 |
-7.55% |
| Jun 30, 2023 |
-15.16% |
| Mar 31, 2023 |
-0.36% |
| Dec 31, 2022 |
-24.22% |
| Sep 30, 2022 |
-3.29% |
| Jun 30, 2022 |
-44.48% |
| Mar 31, 2022 |
-34.88% |
| Dec 31, 2021 |
-8.63% |
| Sep 30, 2021 |
-2.67% |
| Jun 30, 2021 |
-16.70% |
